To Evaluate Safety, Tolerability and Pharmacodynamics of DWRX2003 Against COVID-19 (in Philippines)

COVID-19 Patients Clinical Trial

Official title:
Phase I Study to Evaluate the Safety, Tolerability, and Pharmacodynamics (PD) of DWRX2003 (Niclosamide IM Depot) Injection Following Intramuscular Administration in COVID-19 Patients

Status Terminated

Clinical Trial Summary

This study is designed to assess the safety and tolerability of single doses of DWRX2003 in COVID-19 patients.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT04541485
Study type	Interventional
Source	Daewoong Pharmaceutical Co. LTD.
Contact
Status	Terminated
Phase	Phase 1
Start date	December 4, 2020
Completion date	March 23, 2021

View Details

See also
Status	Clinical Trial	Phase
Not yet recruiting	`NCT04592835` - To Evaluate the Safety, Tolerability and Pharmacokinetic Properties of DWRX2003	Phase 1
Not yet recruiting	`NCT05083104` - Assessment of the Natural Anticoagulant Profile in Patients With COVID-19
Completed	`NCT05162534` - Independent Predictors on Clinical Outcomes in SARS-CoV2 Patients
Completed	`NCT04853979` - Awake Prone Positioning in COVID-19 Suspects With Hypoxemic Respiratory Failure	N/A
Completed	`NCT05369676` - To Evaluate SSD8432/ Ritonavir in Adults With COVID-19	Phase 1/Phase 2
Completed	`NCT05901337` - Cupping Therapy on Immune System in Post Covid -19	N/A
Recruiting	`NCT06349720` - Investigating Long-term Health Effects and Complications in COVID-19 Recoveries
Completed	`NCT04407130` - Efficacy and Safety of Ivermectin and Doxycycline in Combination or IVE Alone in Patients With COVID-19 Infection.	Phase 2
Not yet recruiting	`NCT04427878` - Is Adipose Tissue a Reservoir for SARS-Cov2 Spread in Covid-19 Patients?	N/A
Withdrawn	`NCT04374903` - Hydroxychloroquine in Combination With Sirolimus and Dexamethasone for Treating COVID-19 Patients	N/A